Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Sirnaomics Ltd. ( (HK:2257) ).
Sirnaomics Ltd. has announced a change in the composition of its board committee, with the appointment of Dr. Cheung Hoi Yu as an independent non-executive director and member of the audit committee, effective February 19, 2025. This move ensures the company’s compliance with the Listing Rules of The Stock Exchange of Hong Kong, marking a significant step in aligning with regulatory requirements and strengthening its corporate governance framework.
More about Sirnaomics Ltd.
Sirnaomics Ltd. operates in the biotechnology industry, focusing on the development of RNAi therapeutics for the treatment of diseases, particularly targeting oncology and fibrosis-related conditions.
YTD Price Performance: -9.54%
Average Trading Volume: 137,128
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$329.2M
Learn more about 2257 stock on TipRanks’ Stock Analysis page.